1. Wang, Q-Y, Liu, Y-J, Hu, Y, Xia, L-L, Wu, Y-G. . Prognostic and immune roles of UROC1 in human cancers: from mechanism exploration of NAFLD and HCC to pan-cancer analysis. In European review for medical and pharmacological sciences, 28, 622-644. doi:10.26355/eurrev_202401_35059. https://pubmed.ncbi.nlm.nih.gov/38305606/
2. Espinós, C, Pineda, M, Martínez-Rubio, D, Palau, F, Artuch, R. 2009. Mutations in the urocanase gene UROC1 are associated with urocanic aciduria. In Journal of medical genetics, 46, 407-11. doi:10.1136/jmg.2008.060632. https://pubmed.ncbi.nlm.nih.gov/19304569/
3. Glinton, Kevin E, Levy, Harvey L, Kennedy, Adam D, Pappan, Kirk L, Elsea, Sarah H. 2018. Untargeted metabolomics identifies unique though benign biochemical changes in patients with pathogenic variants in UROC1. In Molecular genetics and metabolism reports, 18, 14-18. doi:10.1016/j.ymgmr.2018.12.005. https://pubmed.ncbi.nlm.nih.gov/30619714/
4. Zhang, Xiuzhi, Kang, Chunyan, Li, Ningning, Gao, Fenglan, Dai, Liping. 2019. Identification of special key genes for alcohol-related hepatocellular carcinoma through bioinformatic analysis. In PeerJ, 7, e6375. doi:10.7717/peerj.6375. https://pubmed.ncbi.nlm.nih.gov/30755830/